Clinical trial
Vinorelbine in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung…
NCT00005865 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00005865 |
|---|---|
| Title | Vinorelbine in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer |
| Official title | A Research Study Evaluating Oral and Intravenous NAVELBINE as a Single Agent for the Treatment of Chemotherapy-Naive Subjects With Inoperable Stage IIIb or Stage IV Non-Small Cell Lung Cancer |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Lung Cancer |
| Intervention type | Drug |
| Interventions | vinorelbine tartrate |
| Start date | Apr 1, 2000 |
| Completion | Jun 1, 2007 |
| First posted | Mar 24, 2004 |
| Last update posted | Jan 6, 2014 |
| Countries | Canada, Puerto Rico, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: